Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P25189: Variant p.Ser63Phe

Myelin protein P0
Gene: MPZ
Feedback?
Variant information Variant position: help 63 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Serine (S) to Phenylalanine (F) at position 63 (S63F, p.Ser63Phe). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to large size and aromatic (F) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In CMT1B. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 63 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 248 The length of the canonical sequence.
Location on the sequence: help GSRVTLHCSFWSSEWVSDDI S FTWRYQPEGGRDAISIFHYA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         GSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYA

Mouse                         GSQVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYA

Rat                           GSQVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYA

Bovine                        GSQVTLYCSFWSSEWVSDDLSFTWRYQPEGGRDAISIFHYA

Horse                         GSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYA

Chicken                       GSHVTLSCSFWSSEWISEDISYTWHFQAEGSRDSISIFHYG

Xenopus laevis                GSRVTLSCSFWSSEWISDDISVTWHYQPDHSREMYSIVHFA

Xenopus tropicalis            GSRVTLSCSFWSSEWISDDVSVTWHYQPDHSREMYSIFHYA
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 30 – 248 Myelin protein P0
Topological domain 30 – 153 Extracellular
Domain 30 – 143 Ig-like V-type
Disulfide bond 50 – 127
Beta strand 63 – 70



Literature citations
Charcot-Marie-Tooth type 1B neuropathy: third mutation of serine 63 codon in the major peripheral myelin glycoprotein PO gene.
Blanquet-Grossard F.; Pham-Dinh D.; Dautigny A.; Latour P.; Bonnebouche C.; Corbillon E.; Chazot G.; Vandenberghe A.;
Clin. Genet. 48:281-283(1995)
Cited for: VARIANT CMT1B PHE-63; Charcot-Marie-Tooth disease type I and related demyelinating neuropathies: mutation analysis in a large cohort of Italian families.
Mostacciuolo M.L.; Righetti E.; Zortea M.; Bosello V.; Schiavon F.; Vallo L.; Merlini L.; Siciliano G.; Fabrizi G.M.; Rizzuto N.; Milani M.; Baratta S.; Taroni F.;
Hum. Mutat. 18:32-41(2001)
Cited for: VARIANTS CMT1B PHE-63 AND MET-124; VARIANTS DSS CYS-98 AND 124-THR-PHE-125 DEL;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.